Literature DB >> 15257086

Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice.

Yanli Ding1, Chun-Shiang Chung, Sarah Newton, Yaping Chen, Stacey Carlton, Jorge E Albina, Alfred Ayala.   

Abstract

Dendritic cells (DCs) are professional antigen-presenting cells that act as sentinels in the cell-mediated response against invading pathogens associated with septic challenge. The purpose of the present study was to determine whether there is a loss of dendritic cells and/or changes in function of these cells in septic mice. Here we report that the number of DCs, in both spleen and peritoneum, decreased over 24 h postsepsis [cecal ligation and puncture (CLP)] when compared with sham. The most dramatic change was seen in the peritoneal cavity. This decrease appeared to be caused mainly by the depletion of immature DCs rather than mature DCs. This change was LPS independent and minimally affected by FasL; however, overexpression of human Bcl-2 gene provides protection of the septic peritoneal DCs. Moreover, although the level of IL-12 release decreased significantly in splenic DCs obtained from CLP mice, IL-12 secretion was markedly elevated by peritoneal DCs as well as in both plasma and peritoneal fluid at 24 h post-CLP. In peritoneal cells, the expression of CD40, CD80, and CD86 was unchanged, but their respective ligands CD40L, CD28, and CD152 all increased in mice 24 h after CLP, although no such change was observed in splenocytes. Regardless of the presence or absence of antigen, peritoneal DCs from CLP mice showed higher capacity to stimulate T-cell proliferation than those cells from the sham control. However, splenic DCs from CLP mice only showed augmented capacity to induce antigen-dependent stimulation of T-cell proliferation. Together, these data indicate that sepsis produces divergent functional changes in splenic and peritoneal DC populations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257086      PMCID: PMC2253681          DOI: 10.1097/01.shk.0000131194.80038.3f

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  46 in total

Review 1.  Why immunomodulatory therapies have not worked in sepsis.

Authors:  E Abraham
Journal:  Intensive Care Med       Date:  1999-06       Impact factor: 17.440

2.  Increased survival in sepsis by in vivo adenovirus-induced expression of IL-10 in dendritic cells.

Authors:  Andreas Oberholzer; Caroline Oberholzer; Keith S Bahjat; Ricardo Ungaro; Cynthia L Tannahill; Michelle Murday; Frances R Bahjat; Zaher Abouhamze; Van Tsai; Drake LaFace; Beth Hutchins; Lyle L Moldawer; Michael J Clare-Salzler
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

3.  Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production.

Authors:  A Ayala; Z K Deol; D L Lehman; C D Herdon; I H Chaudry
Journal:  J Surg Res       Date:  1994-06       Impact factor: 2.192

4.  Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukins-1 and -6 and tumor necrosis factor).

Authors:  A Ayala; M M Perrin; J M Kisala; W Ertel; I H Chaudry
Journal:  Circ Shock       Date:  1992-03

5.  Use of the fluorescence activated cell sorter to enrich dendritic cells from mouse spleen.

Authors:  M T Crowley; K Inaba; M D Witmer-Pack; S Gezelter; R M Steinman
Journal:  J Immunol Methods       Date:  1990-10-04       Impact factor: 2.303

6.  Does endotoxin tolerance prevent the release of inflammatory monokines (interleukin 1, interleukin 6, or tumor necrosis factor) during sepsis?

Authors:  A Ayala; J M Kisala; J A Felt; M M Perrin; I H Chaudry
Journal:  Arch Surg       Date:  1992-02

7.  Dysregulation of in vitro cytokine production by monocytes during sepsis.

Authors:  C Munoz; J Carlet; C Fitting; B Misset; J P Blériot; J M Cavaillon
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

8.  Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.

Authors:  Rosa C S Vianna; Rachel N Gomes; Fernando A Bozza; Rodrigo T Amâncio; Patrícia T Bozza; Cid M N David; Hugo C Castro-Faria-Neto
Journal:  Shock       Date:  2004-02       Impact factor: 3.454

9.  Role of interleukin 6 and transforming growth factor-beta in the induction of depressed splenocyte responses following sepsis.

Authors:  A Ayala; J B Knotts; W Ertèl; M M Perrin; M H Morrison; I H Chaudry
Journal:  Arch Surg       Date:  1993-01

10.  bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages.

Authors:  E Lagasse; I L Weissman
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

View more
  31 in total

1.  BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction.

Authors:  Nicholas J Shubin; Chun S Chung; Daithi S Heffernan; Lydea R Irwin; Sean F Monaghan; Alfred Ayala
Journal:  J Leukoc Biol       Date:  2012-03-29       Impact factor: 4.962

Review 2.  A historical perspective on sepsis.

Authors:  Peter A Ward; Markus Bosmann
Journal:  Am J Pathol       Date:  2012-05-26       Impact factor: 4.307

3.  Characterization of transglutaminase type II role in dendritic cell differentiation and function.

Authors:  Ivana Matic; Alessandra Sacchi; Alessandra Rinaldi; Gennaro Melino; Chaitan Khosla; Laura Falasca; Mauro Piacentini
Journal:  J Leukoc Biol       Date:  2010-04-06       Impact factor: 4.962

4.  Severe sepsis exacerbates cell-mediated immunity in the lung due to an altered dendritic cell cytokine profile.

Authors:  Haitao Wen; Cory M Hogaboam; Jack Gauldie; Steven L Kunkel
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

5.  Selective effect of burn injury on splenic CD11c(+) dendritic cells and CD8alpha(+)CD4(-)CD11c(+) dendritic cell subsets.

Authors:  Julie Patenaude; Michele D'Elia; Claudine Hamelin; Jacques Bernier
Journal:  Cell Mol Life Sci       Date:  2010-01-20       Impact factor: 9.261

6.  Combination therapy with thymosin alpha1 and dexamethasone helps mice survive sepsis.

Authors:  Xiao-song Xiang; Ning Li; Yun-zhao Zhao; Qiu-rong Li; Jie-shou Li
Journal:  Inflammation       Date:  2014-04       Impact factor: 4.092

Review 7.  P2X4 receptors, immunity, and sepsis.

Authors:  Luca Antonioli; Corrado Blandizzi; Matteo Fornai; Pál Pacher; H Thomas Lee; György Haskó
Journal:  Curr Opin Pharmacol       Date:  2019-03-25       Impact factor: 5.547

Review 8.  The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients.

Authors:  Nicholas S Ward; Brian Casserly; Alfred Ayala
Journal:  Clin Chest Med       Date:  2008-12       Impact factor: 2.878

9.  CD40 and CD80/86 act synergistically to regulate inflammation and mortality in polymicrobial sepsis.

Authors:  Anna Nolan; Michael Weiden; Ann Kelly; Yoshihiko Hoshino; Satomi Hoshino; Nehal Mehta; Jeffrey A Gold
Journal:  Am J Respir Crit Care Med       Date:  2007-11-07       Impact factor: 21.405

10.  Diversity of interferon gamma and granulocyte-macrophage colony-stimulating factor in restoring immune dysfunction of dendritic cells and macrophages during polymicrobial sepsis.

Authors:  Stefanie B Flohé; Hemant Agrawal; Sascha Flohé; Meenakshi Rani; Jörg M Bangen; F Ulrich Schade
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.